Remifentanil Hydrochloride 63323-0724
Product NDC
63323-0724- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- January 19, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA206223
Active Ingredients
| Ingredient | Strength |
|---|---|
| Remifentanil Hydrochloride | 1 mg/mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(1)
10 VIAL, SINGLE-DOSE in 1 CARTON (63323-724-05) / 5 mL in 1 VIAL, SINGLE-DOSE (63323-724-01)